RE: Sheffield Uni16 Apr 2024 15:25
Prostate cancer and "cell dormancy "
Dr Green said the funding, of £2.34m from The Wellcome Trust and £500,000 from Yorkshire Cancer Research, would "bring together international experts to gain a deeper understanding of cancer cell dormancy in myeloma".
"By better understanding the cells, this research can either make Karonudib more effective, or may help generate completely new treatments," she said.
She said the additional money from Yorkshire Cancer Research would also fund research into cell dormancy in cancers that spread to bone, like breast and prostate cancer.